AR and neoplasm: A total of 38 out of the 51 TNBC cases (75%) exhibited no androgen receptor positivity within the tumor cells, whereas 5 cases (10%) showed a strong androgen receptor positivity in almost all tumor cells, 6 cases an intermediate positivity in >1% of the tumor cells (12%), and 2 samples could not be evaluated due to missing cores.